IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Katz, M. L.
Right arrow Articles by Gao, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Katz, M. L.
Right arrow Articles by Gao, C. L.

Investigative Ophthalmology & Visual Science, Vol 40, 175-181, Copyright © 1999 by Association for Research in Vision and Ophthalmology


ARTICLES AND REPORTS

Reversible accumulation of lipofuscin-like inclusions in the retinal pigment epithelium

ML Katz, LM Rice and CL Gao
Mason Eye Institute, University of Missouri School of Medicine, Columbia 65212, USA.

PURPOSE: The amounts of autofluorescent lysosomal storage bodies, known as lipofuscin, increase during senescence in the retinal pigment epithelia (RPEs) of mammalian eyes. This increase in lipofuscin content may result from a failure of the RPE to dispose of any lipofuscin constituents once they have formed. Alternatively, the RPE may eliminate lipofuscin but at a rate insufficient to prevent its accumulation. Experiments were conducted to distinguish between these two possibilities. METHODS: Albino rats were given intravitreal injections of the protease inhibitor leupeptin, which induces a rapid accumulation of lipofuscin-like inclusions in the RPE. The amount of these inclusions in the RPE was monitored as a function of time after the leupeptin treatment with quantitative ultrastructural analysis. In addition, the intensity of lipofuscin-specific fluorescence in the RPE was monitored over the same time period with the use of quantitative microfluorometry. These parameters were also followed in untreated control eyes of age-matched animals. RESULTS: A single leupeptin injection resulted in a rapid massive accumulation of electron-dense inclusion bodies in the RPE. These inclusions appeared to be derived primarily from phagocytosed photoreceptor outer segments. Accompanying the accumulation of these inclusions was a significant increase in lipofuscin-specific fluorescence in the RPE. Over a 12-week period after the leupeptin treatment, the amounts of inclusion material and the fluorescence intensities returned to normal levels. CONCLUSIONS: These findings suggest that the age-related increase in RPE lipofuscin content results from an imbalance in the rates of lipofuscin formation and disposal rather than from a complete absence of a disposal mechanism. The results imply that turnover of lipofuscin constituents may be rapid relative to the animals' life span. Thus, it may be possible to slow or reverse the age-related increase in RPE lipofuscin content by either inhibiting the processes involved in lipofuscin formation or enhancing the disposal processes.


This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Zakliczynski, J. Nozynski, D. Konecka-Mrowka, A. Krynicka-Mazurek, M. Swierad, M. Maruszewski, R. Przybylski, and M. Zembala
Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: Are they related to the development of cardiac allograft vasculopathy?
J. Thorac. Cardiovasc. Surg., July 1, 2009; 138(1): 215 - 221.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. Okubo, M. Sameshima, K. Unoki, F. Uehara, and A. C. Bird
Ultrastructural Changes Associated with Accumulation of Inclusion Bodies in Rat Retinal Pigment Epithelium
Invest. Ophthalmol. Vis. Sci., December 1, 2000; 41(13): 4305 - 4312.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. L. Mata, J. Weng, and G. H. Travis
Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration
PNAS, June 13, 2000; (2000) 130110497.
[Abstract] [Full Text]


Home page
IOVSHome page
A. Terman, U. T. Brunk, and M. L. Katz
Is Lipofuscin Eliminated from Cells?
Invest. Ophthalmol. Vis. Sci., September 1, 1999; 40(10): 2463 - 2464.
[Full Text] [PDF]


Home page
IOVSHome page
S. Davies, S. Ellis, M. L. Katz, L. M. Rice, and C. Gao
Lipofuscin Turnover
Invest. Ophthalmol. Vis. Sci., July 1, 1999; 40(8): 1887 - 1888.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. L. Mata, J. Weng, and G. H. Travis
Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration
PNAS, June 20, 2000; 97(13): 7154 - 7159.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Association for Research in Vision and Ophthalmology